Description of Hepcvir L - 12 weeks
Hepcvir L 12 weeks
Brand name: Hepcvir L
Active Ingeridents(Generic Name) : Ledipasvir & Sofosbuvir
Company Name: Cipla
Package: 28 tablets/bottle
Strength : Ledipasvir 90mg & Sofosbuvir 400mg
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Mechanism of action:
Ledipasvir is a potent inhibitor of HCV NS5A, a viral phosphoprotein that plays an important role in viral replication, assembly, and secretion. Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase the key enzyme mediating HCV RNA replication. The triphosphate form of sofosbuvir (GS-461203) mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand, resulting in viral chain termination.
Dosage and Administration:
Ledipasvir-sofosbuvir (90 mg/400 mg) is a fixed-dose combination tablet . The recommended dosage is one tablet once daily, with or without food.
The following are the Common side effects
Tell your doctor or dentist that you take ledipasvir and sofosbuvir before you receive any medical or dental care, emergency care, or surgery.
Do not share needles, injection supplies, or items like toothbrushes or razors. Talk with your health care provider about ways to prevent the spread of HCV to others.
Store: ledipasvir & Sofosbuvir room temperature away from moisture and heat
Buy Hepcvir L 12 week tablet online at best price contact Apple Pharmaceuticals.
Pharmacology of Hepcvir L - 12 weeks
Indication of Hepcvir L - 12 weeks
Dose & Dosage's of Hepcvir L - 12 weeks
Side Effects of Hepcvir L - 12 weeks
Contraindication of Hepcvir L - 12 weeks
Drug Interaction of Hepcvir L - 12 weeks
Precaution of Hepcvir L - 12 weeks
Usage & Safety profile of Hepcvir L - 12 weeks Pregnancy & Lactation
Storage of Hepcvir L - 12 weeks